Purigen Debuts New Advanced Technology System to Simplify and Improve the Purification of Nucleic Acids from Precious Clinical Genomic Samples
BALTIMORE--(BUSINESS WIRE)--Nov 6, 2019--
Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of its Ionic™ Purification System. The small benchtop system utilizes the company’s core isotachophoresis (ITP) technology to extract, purify, and concentrate nucleic acids from biological samples in one hour with less than three minutes of hands-on time per sample. Purigen will unveil the new system and present data during the Association for Molecular Pathology (AMP) 2019 Annual Meeting and Expo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191106005269/en/
The new Ionic™ Purification System from Purigen produces higher yields of pure, ready-to-sequence nucleic acids in one hour with less than three minutes of hands-on time per sample. (Graphic: Business Wire)
The Ionic Purification System enables the automated extraction of nucleic acids with dramatically increased yields and improved purity from a wide range of sample types, including cultured or sorted cells and formalin-fixed, paraffin-embedded (FFPE) tissues. Biological samples are gently lysed and then loaded into the Ionic™ Fluidics Chip. The Ionic system then applies an electric field to the chip and the nucleic acids are isolated in their natural, native form using the company’s proprietary ITP technology. The nucleic acids are not denatured or dehydrated, and there is no binding or stripping from fixed surfaces. The process minimizes fragmentation and eliminates any bead or buffer contamination. The extracted nucleic acids are pure, abundant, and ready for analysis by any downstream technique such as next-generation sequencing or PCR.
Ionic Purification System Components
“The new Ionic Purification System will fundamentally change how nucleic acids are purified from precious samples prior to downstream analysis using NGS and PCR,” said Barney Saunders, PhD, CEO of Purigen. “When working with challenging sample types such as FFPE, or with small tissue samples, the ability to purify nucleic acids with maximal yield and quality is crucial. More abundant and higher-quality nucleic acids allow for superior quality data, which provides researchers with improved biological insights and empowers clinicians with more actionable information.”
The Ionic Purification System is available now through Purigen’s direct sales channels. For more information, please visit: https://www.purigenbio.com/products/ionic-system.
Association for Molecular Pathology Annual Meeting
Purigen will present data and showcase its new Ionic Purification System in booth #3139 at the AMP 2019 Annual Meeting in Baltimore on November 7-9, 2019. For more information on the company’s AMP activities, please visit http://bit.ly/purigenamp2019.
Purigen Corporate Workshop
The New Ionic Purification System from Purigen Biosystems – Automated DNA Purification from FFPE Samples without Bias
Baltimore Convention Center, Room 341
Wednesday, November 6 th at 10:00am – 10:50am
Scientific Poster Presentation
Using Isotachophoresis as a Novel Method to Improve the Yield and Quality of Nucleic Acid Purification from FFPE Samples
Poster Number: G049
Saturday, November 9 th at 9:45am – 10:45am and throughout the meeting in booth 3139
About Purigen Biosystems
Purigen Biosystems is redefining nucleic acid sample preparation with an innovative platform based on the highly efficient isotachophoresis technology invented by Juan Santiago, PhD, and his team at Stanford University. Purigen’s automated benchtop instrumentation and accompanying microfluidic chip purify nucleic acid samples from a wide variety of sources, including minute or otherwise challenging cancer samples. The purified nucleic acids are then immediately compatible with a wide range of downstream detection methods, including next-generation sequencing, PCR, and other genomic tests. For more information, visit www.purigenbio.com.
Ionic is a trademark of Purigen Biosystems, Inc. All other trademarks are the property of their respective owners. All products described herein are intended FOR RESEARCH USE ONLY and NOT FOR USE IN DIAGNOSTIC PROCEDURES.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005269/en/
CONTACT: Nicole Litchfield
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MARYLAND
INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH MEDICAL DEVICES
SOURCE: Purigen Biosystems
Copyright Business Wire 2019.
PUB: 11/06/2019 08:00 AM/DISC: 11/06/2019 08:01 AM